Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

698 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators. Saraf A, et al. Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18. Nat Med. 2024. PMID: 38637636 Free PMC article. Clinical Trial.
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India.
Sinha S, N K, Suram VK, Chary SS, Naik S, Singh VB, Jain MK, Suthar CP, Borthakur S, Sawardekar V, Sk N, Reddy N, Talluri L, Thakur P, Reddy M, Panapakam M, Vattipalli R. Sinha S, et al. Among authors: jain mk. Cureus. 2022 Nov 14;14(11):e31508. doi: 10.7759/cureus.31508. eCollection 2022 Nov. Cureus. 2022. PMID: 36532902 Free PMC article.
Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD.
Salvi S, Jain MK, Krishnamurthy S, Balki A, Kodgule R, Tandon M, Bhagat S, Panchal S, Khatri N, Wu W, Pendse A, Patil S, Barkate H. Salvi S, et al. Among authors: jain mk. Lung India. 2022 Nov-Dec;39(6):517-524. doi: 10.4103/lungindia.lungindia_136_22. Lung India. 2022. PMID: 36629230 Free PMC article.
Colchicine to reduce coronavirus disease-19-related inflammation and cardiovascular complications in high-risk patients post-acute infection with SARS-COV-2-a study protocol for a randomized controlled trial.
Thankachen SS, Devasenapathy N, Bassi A, Ghosh A, Arfin S, Gummidi B, Basheer A, Bangi A, Sahu D, Bhalla A, Blesson M, Jain M, Jha V. Thankachen SS, et al. Trials. 2024 Jun 12;25(1):378. doi: 10.1186/s13063-024-08205-7. Trials. 2024. PMID: 38863076 Free PMC article.
Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial.
O'Hara DV, Bassi A, Wilcox A, Jha V, Rathore V, D'Cruz S, Snelling TL, Jones M, Totterdell J, Bangi A, Jain MK, Pollock C, Burrell L, Fox G, Jones C, Kotwal S, Faridah Syed Omar S, Jardine M; CLARITY 2.0 trial investigators. O'Hara DV, et al. Among authors: jain mk. BMJ Open. 2024 Oct 22;14(10):e081790. doi: 10.1136/bmjopen-2023-081790. BMJ Open. 2024. PMID: 39438096 Free PMC article. Clinical Trial.
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®).
Singh C, Verma S, Reddy P, Diamond MS, Curiel DT, Patel C, Jain MK, Redkar SV, Bhate AS, Gundappa V, Konatham R, Toppo L, Joshi AC, Kushwaha JS, Singh AP, Bawankule S, Ella R, Prasad S, Ganneru B, Chiteti SR, Kataram S, Vadrevu KM. Singh C, et al. Among authors: jain mk. NPJ Vaccines. 2023 Aug 18;8(1):125. doi: 10.1038/s41541-023-00717-8. NPJ Vaccines. 2023. PMID: 37596281 Free PMC article.
Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum.
Ferreira D, Przybelski SA, Lesnick TG, Diaz-Galvan P, Schwarz CG, Murray MM, Dickson DW, Nguyen A, Reichard RR, Senjem ML, Gunter JL, Jack CR Jr, Min PH, Jain MK, Miyagawa T, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Ramanan VK, Jones DT, Botha H, St Louis EK, Knopman DS, Graff-Radford NR, Day GS, Ferman TJ, Kremers WK, Petersen RC, Boeve BF, Lowe VJ, Kantarci K. Ferreira D, et al. Among authors: jain mk. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4643. Online ahead of print. JAMA Neurol. 2025. PMID: 39804619
698 results